HopeStage
Back to all studies
RecruitingNCT06901687

Home-based brain stimulation for depression in multiple sclerosis

About this titleRead the official source — NCT06901687
Device studyAges 18–65United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: August 11, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
170
Sponsor
NYU Langone Health
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT06901687
Official title
Show the full official title

Home-Based tDCS for Depression in Multiple Sclerosis: A Randomized Sham-Controlled Trial

Recruitment & locations

Currently recruiting

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is NYU Langone Health.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies